Skip to main content
. 2019 Sep 7;11(9):1328. doi: 10.3390/cancers11091328

Figure 9.

Figure 9

Diagrammatic illustration shows NETosis regulation by anthracyclines. Neutrophils activated either with NOX-dependent (agonists; PMA, LPS) or -independent (agonists; A23187, Ionomycin) induces NETs release through the activation of respective ROS, kinases, and transcriptional firing. Anthracycline compounds intercalate between DNA base pairs and stop the unwinding, decondensation and transcriptional firing to stop the NETosis. Since this step is downstream of the ROS, these drugs are helpful in suppressing the NETs release with maintaining the neutrophils ROS generation capacity.